Lanzamiento Enero 2027

Estudio de cohortes2020Acceso abierto

Vitamin D, magnesium, calcium, and their interaction in relation to colorectal cancer recurrence and all-cause mortality

Wesselink E, Kok DE, Bours MJL, de Wilt JHW, van Baar H, van Zutphen M, Geijsen AMJR, Keulen ETP, Hansson BME, van den Ouweland J, Witkamp RF, Weijenberg MP, Kampman E, van Duijnhoven FJB

The American journal of clinical nutrition · 41 citas

Cómo se estudió

Diseño
Estudio de cohortes (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Eventos clínicos como enfermedad o muerte

Quién lo pagó

Financiación
Financiación independiente
Organización sin fines de lucro
World Cancer Research Fund International
Organización sin fines de lucro
Health Foundation Limburg
Gobierno
ZonMw
Universidad u hospital
Universiteit Maastricht
Universidad u hospital
Maastricht Universitair Medisch Centrum
Organización sin fines de lucro
KWF Kankerbestrijding
Universidad u hospital
Radboud Universitair Medisch Centrum
Organización sin fines de lucro
Wereld Kanker Onderzoek Fonds
Universidad u hospital
Wageningen University and Research
Organización sin fines de lucro
Alpe d'Huzes/Dutch Cancer Society
Organización sin fines de lucro
Leven met kanker” of the Dutch Cancer Society
Gobierno
ERA-NET on Translational Cancer Research
Organización sin fines de lucro
Dutch Cancer Society
Organización sin fines de lucro
Kankeronderzoekfonds Limburg
Gobierno
Netherlands Organization for Health Research and Development
Subvenciones
KWF Kankerbestrijding (UW2014-6877); KWF Kankerbestrijding (UW2013‐6397); World Cancer Research Fund International (2014/1179); Health Foundation Limburg (00005739)

Según 15 financiadores declarados y la declaración de financiación del texto completo.

Publicación

Publicado
2020-02-25 · Am J Clin Nutr · vol. 111 · número 5 · págs. 1007–1017
Editorial
Elsevier BV
Citado
63 citas · más que el 95% de estudios similares · 4.3× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
43 trabajos
Acceso
Acceso abierto (revista híbrida) · CC-BY-NC
Áreas de investigación
Vitamin D Research Studies · Magnesium in Health and Disease · Parathyroid Disorders and Treatments
Palabras clave
Magnesium, Vitamin D and neurology, Medicine, Calcium, Hazard ratio, Proportional hazards model, Internal medicine, Colorectal cancer, Gastroenterology, Vitamin, Endocrinology, Population, Cancer, Chemistry, Confidence interval
MeSH
humans, colorectal neoplasms, neoplasm recurrence, local, calcium, magnesium, calcifediol, vitamin d, neoplasm staging, longitudinal studies, prospective studies, dietary supplements, aged, middle aged, female, male

14 autores

  • Evertine Wesselink🇳🇱 · autor de correspondenciaWageningen University & Research
  • Dieuwertje E. G. Kok🇳🇱Wageningen University & Research
  • Martijn J.L. Bours🇳🇱Maastricht University
  • Johannes H.W. de Wilt🇳🇱Radboud University Nijmegen; Radboud University Medical Center
  • Harm van Baar🇳🇱Wageningen University & Research
  • Moniek van Zutphen🇳🇱Wageningen University & Research
  • Anne J. M. R. Geijsen🇳🇱Wageningen University & Research
  • Eric T.P. Keulen🇳🇱Zuyderland Medisch Centrum
  • Bibi M. E. Hansson🇳🇱Canisius-Wilhelmina Ziekenhuis
  • Jody van den Ouweland🇳🇱Canisius-Wilhelmina Ziekenhuis
  • Renger F. Witkamp🇳🇱Wageningen University & Research
  • Matty P. Weijenberg🇳🇱Maastricht University
  • Ellen Kampman🇳🇱Wageningen University & Research
  • Fränzel J.B. van Duijnhoven🇳🇱Wageningen University & Research

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

Higher concentrations of 25-hydroxyvitamin D3 [25(OH)D3] at diagnosis are associated with a lower mortality risk in colorectal cancer (CRC) patients. However, magnesium and calcium are important in vitamin D metabolism.

Objectives

We aimed to investigate 25(OH)D3, magnesium, or calcium and their interaction among patients with CRC in relation to recurrence and all-cause mortality.

Methods

The study population included 1169 newly diagnosed stage I-III CRC patients from 2 prospective cohorts. Associations between 25(OH)D3 concentrations, magnesium or calcium intake through diet and/or supplements at diagnosis, and recurrence and all-cause mortality were evaluated using multivariable Cox proportional hazard models. The interaction between 25(OH)D3 and magnesium or calcium was assessed by investigating 1) joint compared with separate effects, using a single reference category; and 2) the effect estimates of 1 factor across strata of another.

Results

Serum 25(OH)D3, calcium, and magnesium, alone and their interactions, were not associated with recurrence. Serum 25(OH)D3 concentrations seemed to be associated with all-cause mortality. An inverse association between magnesium intake (HRQ3 vs. Q1: 0.55; 95% CI: 0.32, 0.95 and HRQ4 vs. Q1: 0.65; 95% CI: 0.35, 1.21), but not calcium intake, and all-cause mortality was observed. When investigating the interaction between 25(OH)D3 and magnesium, we observed the lowest risk of all-cause mortality in patients with sufficient vitamin D concentrations (≥50 nmol/L) and a high magnesium intake (median split) (HR: 0.53; 95% CI: 0.31, 0.89) compared with patients who were vitamin D deficient (<50 nmol/L) and had a low magnesium intake. No interactions between calcium and vitamin D in relation to all-cause mortality were observed.

Conclusions

Our findings suggest that the presence of an adequate status of 25(OH)D3 in combination with an adequate magnesium intake is essential in lowering the risk of mortality in CRC patients, yet the underlying mechanism should be studied. In addition, diet and lifestyle intervention studies are needed to confirm our findings. The COLON study was registered at clinicaltrials.gov as NCT03191110. The EnCoRe study was registered at trialregister.nl as NTR7099.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY-NC).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.